Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Mylan Products Ltd., Station Close, Potters Bar, Hertfordshire, EN6 1TL, UK
Difflam 3 mg Lozenges, mint flavour.
| Pharmaceutical Form |
|---|
|
Lozenge. Green square-shaped lozenges, with a central cavity. |
Each lozenge contains 3 mg of benzydamine hydrochloride equivalent to 2.68 mg benzydamine.
Excipients with known effects: each lozenge contains 3183 mg of Isomalt (E953) and 3.5 mg of Aspartame (E951).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Benzydamine |
Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis. |
| List of Excipients |
|---|
|
Isomalt (E953) |
Lozenge is wrapped in paraffin paper.
Ten lozenges are wrapped together in printed polyethylene-paper-aluminium trilaminated material.
Each pack contains 20 or 30 lozenges (two or three packets of ten lozenges each).
Not all pack size may be marketed.
Mylan Products Ltd., Station Close, Potters Bar, Hertfordshire, EN6 1TL, UK
PL 46302/0095
Date of first authorisation: 30/01/2001
Date of latest renewal: 06/08/2010
| Drug | Countries | |
|---|---|---|
| DIFFLAM | Australia, Cyprus, Hong Kong, Ireland, Malta, New Zealand, Singapore, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
